These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28751834)

  • 21. Statin Intolerance: A Review and Update.
    Tsushima Y; Hatipoglu B
    Endocr Pract; 2023 Jul; 29(7):566-571. PubMed ID: 36958647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin Intolerance: A Literature Review and Management Strategies.
    Saxon DR; Eckel RH
    Prog Cardiovasc Dis; 2016; 59(2):153-164. PubMed ID: 27497504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence.
    Citarella A; Linder M; Kieler H; Berglind IA; Sundström A; Wettermark B; Andersen M
    Eur J Clin Pharmacol; 2016 Mar; 72(3):349-57. PubMed ID: 26671240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
    Stroes ES; Thompson PD; Corsini A; Vladutiu GD; Raal FJ; Ray KK; Roden M; Stein E; Tokgözoğlu L; Nordestgaard BG; Bruckert E; De Backer G; Krauss RM; Laufs U; Santos RD; Hegele RA; Hovingh GK; Leiter LA; Mach F; März W; Newman CB; Wiklund O; Jacobson TA; Catapano AL; Chapman MJ; Ginsberg HN;
    Eur Heart J; 2015 May; 36(17):1012-22. PubMed ID: 25694464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates.
    Baessler A; Fischer M; Huf V; Mell S; Hengstenberg C; Mayer B; Holmer S; Riegger G; Schunkert H
    Int J Cardiol; 2005 May; 101(2):293-8. PubMed ID: 15882678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of statin intolerance.
    Raju SB; Varghese K; Madhu K
    Indian J Endocrinol Metab; 2013 Nov; 17(6):977-82. PubMed ID: 24381870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of statin-intolerant patient.
    Arca M; Pigna G; Favoccia C
    Panminerva Med; 2012 Jun; 54(2):105-18. PubMed ID: 22525565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Algorithms to Identify Statin Intolerance in Medicare Administrative Claim Data.
    Colantonio LD; Kent ST; Huang L; Chen L; Monda KL; Serban MC; Manthripragada A; Kilgore ML; Rosenson RS; Muntner P
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):525-533. PubMed ID: 27389413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance.
    Thompson PD; Rubino J; Janik MJ; MacDougall DE; McBride SJ; Margulies JR; Newton RS
    J Clin Lipidol; 2015; 9(3):295-304. PubMed ID: 26073387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
    Ambegaonkar BM; Tipping D; Polis AB; Tomassini JE; Tershakovec AM
    Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle.
    Glueck CJ; Abuchaibe C; Wang P
    Med Hypotheses; 2011 Oct; 77(4):658-61. PubMed ID: 21802861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance and intolerance to statins.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2014 Oct; 24(10):1057-66. PubMed ID: 24996502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Low-Dose Statin Versus Low-Dose Statin + Armolipid Plus in High-Intensity Statin-Intolerant Patients With a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial).
    Marazzi G; Campolongo G; Pelliccia F; Quattrino S; Vitale C; Cacciotti L; Massaro R; Volterrani M; Rosano G
    Am J Cardiol; 2017 Sep; 120(6):893-897. PubMed ID: 28781026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins affect ocular microcirculation in patients with hypercholesterolaemia.
    Terai N; Spoerl E; Fischer S; Hornykewycz K; Haustein M; Haentzschel J; Pillunat LE
    Acta Ophthalmol; 2011 Sep; 89(6):e500-4. PubMed ID: 21457486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New therapies to reduce low-density lipoprotein cholesterol.
    Wierzbicki AS; Viljoen A; Hardman TC; Mikhailidis DP
    Curr Opin Cardiol; 2013 Jul; 28(4):452-7. PubMed ID: 23736819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dyslipidemia: management using optimal lipid-lowering therapy.
    Ito MK
    Ann Pharmacother; 2012 Oct; 46(10):1368-81. PubMed ID: 23032652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.